Peer-influenced content. Sources you trust. No registration required. This is HCN.

Optometric ManagementFDA Recalls More Than 39,000 Bottles of Eye Drops

📋 Regulatory Action / Label Change

The recall affects 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief distributed nationwide. Prestige Brands initiated the voluntary action because of a lack of assurance of sterility and potential contamination. The recall is limited to lot 2552A and was classified by the FDA as a Class II recall, indicating temporary or medically reversible health consequences are possible, while the probability of serious harm is considered remote.


Professional Impact

  • Recall limited to lot 2552A with expiration date September 30, 2027.
  • Concern involves potential contamination and sterility assurance, not product efficacy.
  • Product is sold OTC for redness, itching, burning, and watery eyes.
  • FDA classified the action as a Class II recall rather than the agency’s highest-risk category.

Action Items

  • Verify lot numbers when patients report using the product.
  • Monitor for ocular symptoms potentially associated with recalled product exposure.
  • Review FDA recall updates if additional manufacturing lots are identified.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form